Comparison of the effects of eldecalcitol and alfacalcidol on bone and calcium metabolism

Journal of Steroid Biochemistry and Molecular Biology

Volumn 121, Issue 1-2, 2010, Pages 261-264

  Matsumoto, Toshio ^a   Takano, Toshiyuki ^b   Yamakido, Shinji ^b   Takahashi, Fumiaki ^b   Tsuji, Naoki ^b  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b Chugai Parmaceutical Co Ltd   (Japan)

Author keywords

Alfacalcidol; Bone turnover markers; Calcium metabolism; Eldecalcitol; Osteoporosis

Indexed keywords

2BETA (3 HYDROXYPROPOXY)CALCITRIOL; ALFACALCIDOL; ALKALINE PHOSPHATASE; AMINO TERMINAL TELOPEPTIDE; CALCIUM; ALPL PROTEIN, HUMAN; BIOLOGICAL MARKER; COLLAGEN TYPE 1; COLLAGEN TYPE I TRIMERIC CROSS-LINKED PEPTIDE; ELDECALCITOL; HYDROXYCOLECALCIFEROL; PEPTIDE; VITAMIN D;

ADULT; AGED; ARTICLE; BONE METABOLISM; BONE TURNOVER; CALCIUM BLOOD LEVEL; CALCIUM EXCRETION; CALCIUM METABOLISM; CALCIUM URINE LEVEL; CLINICAL TRIAL; DOSE RESPONSE; FEMALE; HUMAN; JAPANESE; NORMAL HUMAN; OSSIFICATION; OSTEOLYSIS; POSTMENOPAUSE; ANALOGS AND DERIVATIVES; BIOLOGICAL MODEL; BLOOD; BONE; COMPARATIVE STUDY; CONTROLLED STUDY; METABOLISM; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL;

AGED; ALKALINE PHOSPHATASE; BIOLOGICAL MARKERS; BONE AND BONES; BONE RESORPTION; CALCIUM; COLLAGEN TYPE I; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; HYDROXYCHOLECALCIFEROLS; MIDDLE AGED; MODELS, BIOLOGICAL; PEPTIDES; POSTMENOPAUSE; VITAMIN D;

EID: 77954758828     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2010.03.035     Document Type: Article

References (7)

1. Okano T., Tsugawa N., Masuda S., Takeuchi A., Kobayashi T., Nishii Y. A novel synthetic vitamin D3 analogue, 2-beta-(3-hydroxypropoxy)-calcitriol (ED-71): its biological activities and pharmacological effects on calcium metabolism. Contrib. Nephrol. 1991, 91:116-122.
2. Tsurukami H., Nakamura T., Suzuki K., Sato K., Higuchi Y., Nishii Y. A novel synthetic vitamin D analogue, 2 beta-(3-hydroxypropoxy)-1alpha, 25-dihydroxyvitamin D3 (ED-71), increases bone mass by stimulating the bone formation in normal and ovariectomized rats. Calcified Tissue Int. 1994, 54:142-149.
3. Uchiyama Y., Higuchi Y., Takeda S., Masaki T., Shiraishi A., Sato K. ED-71, a vitamin D analog, is a more potent inhibitor of bone resorption than alfacalcidol in an estrogen-deficient rat model of osteoporosis. Bone 2002, 30:582-588.
4. Matsumoto T., Kubodera N., The ED-71 Study Group 1,25-Dihydroxy-2β-(3-hydroxypropoxy) vitamin D3 (ED-71): a promising candidate for the treatment of osteoporosis. Vitamin D Endocrine System: Structural, Biological, Genetic and Clinical Aspects 2000, 985-992. A. Norman, R. Bouillon, M. Thomasset (Eds.).
5. Matsumoto T., Miki T., Hagino H., Sugimoto T., Okamoto S., Hirota T., Tanigawara Y., Hayashi Y., Fukunaga M., Shiraki M., Nakamura T. A new active vitamin D, ED-71, increases bone mass in osteoporotic patients under vitamin D supplementation: a randomized, double-blind, placebo-controlled clinical trial. J. Clin. Endocrinol. Metab. 2005, 90(9):5031-5036.
6. 3, increases bone mineral density regardless of serum 25(OH)D levels in osteoporotic subjects. J. Steroid Biochem. Mol. Biol. 2007, 103:584-586.
7. Hatakeyama S., Nagashima S., Imai N., Takahashi K., Ishihara J., Sugita A., Nihei T., Saito H., Takahashi F., Kubodera N. Synthesis and biological evaluation of a 3-positon epimer of 1,25-dihydroxy-2β-(3-hydroxypropoxy) vitamin D3 (ED-71). J. Steroid Biochem. Mol. Biol. 2007, 103:222-226.